摘要
目的 为进一步提升乳腺癌患者在接受协同治疗过程中的治疗疗效,本研究中给予部分乳腺癌协同治疗患者深部热疗与化疗两者联合治疗,以分析此类治疗方式的疗效。方法 回顾分析广东省东莞市滨海湾中心医院2019年1月-2021年6月收治的40例乳腺癌患者,按治疗方式分组,其中20例接受化疗(多柔比星、表柔比星、环磷酰胺、多西他赛)联合深部热疗治疗(观察组),另20例接受化疗治疗,即化疗使用药物包含多柔比星、表柔比星、环磷酰胺、多西他赛,分别将其划入到本研究中观察组、对照组中,比较治疗效果,如疗效、腋窝积液消失时间、生活质量(QLO-C30评分)等。结果 观察组复发率0%低于对照组5.00%,数据差异无统计学意义(P>0.05);治疗前组间QLO-C30评分差异无统计学意义(P>0.05),治疗后,观察组躯体功能(89.65±1.65)分、角色功能(78.63±1.65)分、认知功能(80.25±2.32)分、情绪功能(78.65±1.24)分高于对照组躯体功能(74.25±1.35)分、角色功能(65.32±2.32)分、认知功能(68.25±1.24)分、情绪功能(61.02±1.35)分,数据有统计学差异(P <0.05);观察组腋窝积液消失时间(0.85±0.21)个月低于对照组(2.21±0.22)个月,数据差异有统计学意义(P <0.05)。结论 进一步提升乳腺癌疾病治疗疗效的有效方式之一则为化疗与深部热疗两者联合使用,并可明显改善各患者生活质量。
Objective To further enhance the therapeutic efficacy of breast cancer patients during receiving synergistic treatment, deep hyperthermia combined with chemotherapy was given to patients with partial breast cancer synergistic treatment in this study to analyze the efficacy of such treatment modalities. Methods A total of 40 breast cancer patients treated in our hospital between January 2019and June 2021 were retrospectively analyzed and grouped according to treatment modality, including 20patients treated with chemotherapy(doxorubicin, epirubicin, cyclophosphamide, docetaxel) combined with deep thermal therapy(observation group) and 20 patients treated with chemotherapy consisting of doxorubicin, epirubicin, cyclophosphamide(observation group)Docetaxel, respectively, were allocated into the observation group and the control group in this study to compare the therapeutic effects, such as efficacy, time to disappearance of axillary effusion, and quality of life(qlo-c30 score). Results The recurrence rate of 0% in the observation group was lower than that of 5.00% in the control group, and the data were not statistically different(P >0.05);There was no statistical difference in qlo-c30 scores between groups before treatment(P >0.05), after treatment, the observed group’s somatic function(89.65±1.65)points, role function(78.63±1.65) points, cognitive function(80.25±2.32) points, emotional Oh function(78.65±1.24) points were higher than the control group’s somatic function(74.25±1.35) points, role function(65.32±2.32) points, cognitive function(68.25±1.24) pointsEmotional Oh function(61.02±1.35)points, the data were statistically different(P <0.05);The disappearance time of axillary effusion in the observation group(0.85±0.21) months was lower than that in the control group(2.21±0.22) months, and the difference in data was statistically significant(P < 0.05). Conclusion One of the effective ways to further enhance the treatment efficacy of breast cancer disease is the combination of chemotherapy and deep hyperthermia, and can obviously improve the quality of life of each patient.
作者
黄胜波
HUANG Shengbo(Guangdong Dongguan Binhai Bay Central Hospital,Dongguan,Guangdong 523900)
出处
《智慧健康》
2022年第10期53-55,共3页
Smart Healthcare
关键词
乳腺癌
化疗
深部热疗
免疫功能
生活质量
疗效
Breast cancer
Chemotherapy
Deep thermal therapy
Immunity
Quality of life
Curative effect
